CORBF
Price
$1.75
Change
-$0.00 (-0.00%)
Updated
Oct 8 closing price
MBOT
Price
$1.00
Change
-$0.02 (-1.96%)
Updated
Oct 9, 01:58 PM (EDT)
23 days until earnings call
Ad is loading...

CORBF vs MBOT

Header iconCORBF vs MBOT Comparison
Open Charts CORBF vs MBOTBanner chart's image
Global Cord Blood
Price$1.75
Change-$0.00 (-0.00%)
Volume$7.56K
CapitalizationN/A
Microbot Medical
Price$1.00
Change-$0.02 (-1.96%)
Volume$1.3K
CapitalizationN/A
View a ticker or compare two or three
CORBF vs MBOT Comparison Chart
Loading...
MBOT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CORBF vs. MBOT commentary
Oct 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CORBF is a Hold and MBOT is a Buy.

COMPARISON
Comparison
Oct 09, 2024
Stock price -- (CORBF: $1.75 vs. MBOT: $1.01)
Brand notoriety: CORBF and MBOT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CORBF: 169% vs. MBOT: 171%
Market capitalization -- CORBF: $154M vs. MBOT: $18.57M
CORBF [@Medical Specialties] is valued at $154M. MBOT’s [@Medical Specialties] market capitalization is $18.57M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CORBF’s FA Score shows that 0 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • CORBF’s FA Score: 0 green, 5 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, CORBF is a better buy in the long-term than MBOT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBOT’s TA Score shows that 5 TA indicator(s) are bullish.

  • MBOT’s TA Score: 5 bullish, 3 bearish.

Price Growth

CORBF (@Medical Specialties) experienced а 0.00% price change this week, while MBOT (@Medical Specialties) price change was +14.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

CORBF is expected to report earnings on Feb 27, 2023.

MBOT is expected to report earnings on Nov 01, 2024.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORBF($154M) has a higher market cap than MBOT($18.6M). CORBF YTD gains are higher at: 43.443 vs. MBOT (-38.415).
CORBFMBOTCORBF / MBOT
Capitalization154M18.6M828%
EBITDAN/A-10.75M-
Gain YTD43.443-38.415-113%
P/E Ratio1.99N/A-
RevenueN/A0-
Total CashN/A8.15M-
Total DebtN/A245K-
FUNDAMENTALS RATINGS
CORBF vs MBOT: Fundamental Ratings
CORBF
MBOT
OUTLOOK RATING
1..100
378
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6498
PRICE GROWTH RATING
1..100
3863
P/E GROWTH RATING
1..100
39100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBOT's Valuation (45) in the Biotechnology industry is in the same range as CORBF (61) in the Medical Or Nursing Services industry. This means that MBOT’s stock grew similarly to CORBF’s over the last 12 months.

MBOT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CORBF (100) in the Medical Or Nursing Services industry. This means that MBOT’s stock grew similarly to CORBF’s over the last 12 months.

CORBF's SMR Rating (64) in the Medical Or Nursing Services industry is somewhat better than the same rating for MBOT (98) in the Biotechnology industry. This means that CORBF’s stock grew somewhat faster than MBOT’s over the last 12 months.

CORBF's Price Growth Rating (38) in the Medical Or Nursing Services industry is in the same range as MBOT (63) in the Biotechnology industry. This means that CORBF’s stock grew similarly to MBOT’s over the last 12 months.

CORBF's P/E Growth Rating (39) in the Medical Or Nursing Services industry is somewhat better than the same rating for MBOT (100) in the Biotechnology industry. This means that CORBF’s stock grew somewhat faster than MBOT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MBOT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
MBOT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL225.774.08
+1.84%
Apple
TSLA244.503.67
+1.52%
Tesla
SPY573.175.37
+0.95%
SPDR® S&P 500® ETF Trust
BTC.X62131.970000-104.691410
-0.17%
Bitcoin cryptocurrency
GME20.71-0.19
-0.91%
GameStop Corp

CORBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORBF has been loosely correlated with SINT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CORBF jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORBF
1D Price
Change %
CORBF100%
N/A
SINT - CORBF
38%
Loosely correlated
N/A
APYX - CORBF
36%
Loosely correlated
-3.15%
MBOT - CORBF
33%
Loosely correlated
+9.78%
QTRX - CORBF
30%
Poorly correlated
+0.79%
BVS - CORBF
30%
Poorly correlated
+3.57%
More

MBOT and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with MASS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
+9.78%
MASS - MBOT
36%
Loosely correlated
+1.45%
NVCR - MBOT
33%
Loosely correlated
+0.34%
CORBF - MBOT
33%
Loosely correlated
N/A
OTCFF - MBOT
30%
Poorly correlated
N/A
SRDX - MBOT
28%
Poorly correlated
-0.16%
More